AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector ...

Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...

Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Two influential advisory firms, Institutional Shareholder Services and Glass Lewis, are rallying investors to vote against AZ’s ...

Matthew Herper covers medical innovation — both its promise and its perils. CHICAGO — Each year, 40,000 cancer researchers, doctors, and industry executives gather here for the biggest meeting in ...

AstraZeneca, having surpassed its long-term $45 billion revenue goal last year, has handsomely rewarded its chief executive. In fact, Pascal Soriot’s compensation package makes him the current top ...

This photo taken on Nov 7, 2025 shows the booth of AstraZeneca at the Medical Equipment and Healthcare Products Exhibition ...

AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...

The most expensive product in modern business is the one that never ships. Nowhere is that more true than in a pharmaceutical lab. A company can spend more than a decade and a fortune chasing a single ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been ...